These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 6040289)

  • 1. [Clinical observations on the use of Endoxan in treatment of peritoneal and pleural carcinomatosis].
    Szulc EJ
    Wiad Lek; 1967 Jan; 20(1):27-30. PubMed ID: 6040289
    [No Abstract]   [Full Text] [Related]  

  • 2. [Local treatment of carcinomatous effusions with triethylenethiophosphoramide (thio-tepa)].
    Schwandt P; Ehrhart H
    Munch Med Wochenschr; 1966 Dec; 108(50):2535-40. PubMed ID: 4166193
    [No Abstract]   [Full Text] [Related]  

  • 3. [Chemotherapy of carcinomatous peritonitis and carcinomatous pleuritis by using activated charcoal particle adsorbing mitomycin C (MMC-CH)--studies on the clinical trials].
    Hagiwara A; Takahashi T; Lee R; Ueda T; Takeda M; Itoh T
    Nihon Gan Chiryo Gakkai Shi; 1985 Oct; 20(9):2144-53. PubMed ID: 3937878
    [No Abstract]   [Full Text] [Related]  

  • 4. Vindesine in the treatment of malignant mesothelioma: a phase II study.
    Kelsen D; Gralla R; Cheng E; Martini N
    Cancer Treat Rep; 1983 Sep; 67(9):821-2. PubMed ID: 6883358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Treatment of peritoneal and pleural carcinomatosis with cytostatic drugs (preparation: E-39 and trenimon)].
    Jodkowski H
    Pol Tyg Lek; 1965 Aug; 20(32):1203-5. PubMed ID: 5845701
    [No Abstract]   [Full Text] [Related]  

  • 6. Chemotherapy treatment of chyloperitoneum and peritoneal carcinomatosis due to cervical cancer--review of literature.
    Keung YK; Whitehead RP; Cobos E
    Gynecol Oncol; 1996 Jun; 61(3):448-50. PubMed ID: 8641632
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Endoxan treatment in cases of inoperable bronchial carcinoma].
    Krzak J
    Gruzlica; 1975 Aug; 43(8):737-41. PubMed ID: 1158179
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of intraperitoneal perfusion of COPP in peritonitis carcinomatosis].
    Kikuchi K; Yamagata S; Yoshizumi M; Watanabe R
    Gan No Rinsho; 1965 Nov; 11(12):834-7. PubMed ID: 5894620
    [No Abstract]   [Full Text] [Related]  

  • 9. Cytoreductive surgery and intraperitoneal hyperthermic chemotherapy in peritoneal carcinomatosis.
    Nesher E; Greenberg R; Avital S; Skornick Y; Schneebaum S
    Isr Med Assoc J; 2007 Nov; 9(11):787-90. PubMed ID: 18085034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Feasibility of using intraperitoneal epinephrine and cisplatin in patients with advanced peritoneal carcinomatosis.
    Molucon-Chabrot C; Isambert N; Benoit L; Zanetta S; Fraisse J; Guilland JC; Royer B; Monin-Baroille P; Flesch M; Fargeot P; Coudert B; Mayer F; Fumoleau P; Chauffert B
    Anticancer Drugs; 2006 Nov; 17(10):1211-7. PubMed ID: 17075321
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Rationale for perioperative chemotherapy treatment in peritoneal carcinomatosis].
    Barrasa A; Van de Speeten K; Anthony Stuart O; Hendrick Sugarbaker P; Zappa L
    Cir Esp; 2009 Jan; 85(1):3-13. PubMed ID: 19239931
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Cytostatic therapy of lung and pleural neoplasms].
    Martz G; Danczkay I
    Bibl Tuberc; 1965; 20():176-85. PubMed ID: 5877566
    [No Abstract]   [Full Text] [Related]  

  • 13. [Intraperitoneal cisplatin plus epinephrine and surgical debulking for the treatment of advanced peritoneal carcinomatosis in the rat].
    Benoit L; Duvillard C; Beltramo JL; Brunet-Lecomte P; Chauffert B
    Gastroenterol Clin Biol; 2000 Jan; 24(1):26-30. PubMed ID: 10679584
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The action of phytohemagglutinin in the prevention and treatment of hematologic side effects of chemotherapy in broncho-pleural-pulmonary cancer].
    Brocard H; Akoun G
    Bull Mem Soc Med Hop Paris; 1967 Jan; 118(2):157-77. PubMed ID: 6061579
    [No Abstract]   [Full Text] [Related]  

  • 15. Treatment of peritoneal carcinomatosis from adenocarcinoid of appendiceal origin.
    Mahteme H; Sugarbaker PH
    Br J Surg; 2004 Sep; 91(9):1168-73. PubMed ID: 15449269
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Collateral effects of intraoperative hyperthermic chemotherapy in peritoneal carcinomatosis].
    Izzo L; Galati G; D'Aprile MR; Stasolla A; Kharrub Z; Maccioni F; Sassayannis PG; D'Arielli D; Marini M; Gazzanelli S; Caputo M
    G Chir; 2004; 25(1-2):43-6. PubMed ID: 15112761
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Combined cytoreductive surgery and intraoperative hyperthermic chemo-perfusion for peritoneal carcinomatosis: methods, postoperative features and end results].
    Tarasov VA; Vinogradova MV; Norbaev ShE; Sharov IuK; Stavrovietskiĭ VV; Adueva SA; Blium MB
    Vopr Onkol; 2006; 52(6):638-42. PubMed ID: 17338240
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The integrated treatment of peritoneal carcinomatosis. A preliminary experience.
    Cavaliere F; Di Filippo F; Cosimelli M; Aloe L; Arcuri E; Anzà M; Callopoli A; Di Lauro L; Morace E; Botti C; Natoli S; Tedesco M; Giunta S; Cavaliere R
    J Exp Clin Cancer Res; 1999 Jun; 18(2):151-8. PubMed ID: 10464701
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Rationale for hyperthermic intraperitoneal chemotherapy (HIPEC) in the treatment or prevention of peritoneal carcinomatosis.
    Detroz B; Laurent S; Honoré P; Blaffart F; Limet R; Meurisse M
    Acta Chir Belg; 2004 Aug; 104(4):377-83. PubMed ID: 15469146
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Intraperitoneal treatment using taxol is effective for experimental peritoneal carcinomatosis in a rat model.
    Hribaschek A; Ridwelski K; Pross M; Meyer F; Kuhn R; Halangk W; Boltze C; Lippert H
    Oncol Rep; 2003; 10(6):1793-8. PubMed ID: 14534698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.